SLP-0901

N/A

Report date: 2024/01/26 17:43:01
NME

Base Information

Drug NameSLP-0901
Drug Alias NameSLP-0901SLP0901
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRecombinant envelope protein inhibitorsCell membrane modulators
TargetsRecombinant envelope protein
Therapy Area/IndicationsMycosesGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSealife Pharma GmbH
China Registration ClassN/A

Develop Information

Active CompaniesSealife Pharma GmbH
Inactive CompaniesN/A
Active IndicationsMycosesGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A